Autotransplantation of mesenchymal stromal cells from bone-marrow to heart in patients with severe stable coronary artery disease and refractory angina - Final 3-year follow-up

International Journal of Cardiology

Volumn 170, Issue 2, 2013, Pages 246-251

  Mathiasen, Anders Bruun ^a   Haack Sørensen, Mandana ^a   Jørgensen, Erik ^a   Kastrup, Jens ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Angiogenesis; Chronic myocardial ischemia; Mesenchymal stromal cell; Refractory angina; Stem cell; Stem cell therapy

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLYCERYL TRINITRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; VASCULOTROPIN;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; AUTOTRANSPLANTATION; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG USE; EXERCISE TEST; FEMALE; FOLLOW UP; HEART MUSCLE ISCHEMIA; HOSPITAL ADMISSION; HUMAN; LONG TERM CARE; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; PATIENT SAFETY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; REVASCULARIZATION; SCORING SYSTEM; SEATTLE ANGINA QUESTIONNAIRE;

ANGIOGENESIS; CHRONIC MYOCARDIAL ISCHEMIA; MESENCHYMAL STROMAL CELL; REFRACTORY ANGINA; STEM CELL; STEM CELL THERAPY;

AGED; ANGINA PECTORIS; BONE MARROW TRANSPLANTATION; CORONARY ARTERY DISEASE; EXERCISE TEST; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIUM; PATIENT READMISSION; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 84889088207     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.10.079     Document Type: Article

References (45)

1. J. Kastrup Stem cells therapy for cardiovascular repair in ischemic heart disease: how to predict and secure optimal outcome? EPMA J 2 2011 107 117
2. C. Toma, M.F. Pittenger, K.S. Cahill, B.J. Byrne, and P.D. Kessler Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart Circulation 105 2002 93 98
3. B. Assmus, A. Rolf, and S. Erbs Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction Circ Heart Fail 3 2010 89 96
4. J.O. Beitnes, E. Hopp, and K. Lunde Long-term results after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: the ASTAMI randomised, controlled study Heart 95 2009 1983 1989
5. S. Fuchs, R. Kornowski, and G. Weisz Safety and feasibility of transendocardial autologous bone marrow cell transplantation in patients with advanced heart disease Am J Cardiol 97 2006 823 829
6. D.M. Leistner, U. Fischer-Rasokat, and J. Honold Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy Clin Res Cardiol 100 2011 925 934
7. D.W. Losordo, R.A. Schatz, and C.J. White Intramyocardial transplantation of autologous CD34 + stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial Circulation 115 2007 3165 3172
8. D.W. Losordo, T.D. Henry, and C. Davidson Intramyocardial, autologous CD34 + cell therapy for refractory angina Circ Res 109 2011 428 436
9. G.P. Meyer, K.C. Wollert, and J. Lotz Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial Eur Heart J 30 2009 2978 2984
10. E.C. Perin, H.F. Dohmann, and R. Borojevic Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy Circulation 110 2004 II213 II218
11. E.C. Perin, G.V. Silva, and T.D. Henry A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF) Am Heart J 161 2011 1078 1087
12. M. Yousef, C.M. Schannwell, M. Kostering, T. Zeus, M. Brehm, and B.E. Strauer The BALANCE study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction J Am Coll Cardiol 53 2009 2262 2269
13. B.E. Strauer, M. Yousef, and C.M. Schannwell The acute and long-term effects of intracoronary stem cell transplantation in 191 patients with chronic heARt failure: the STAR-heart study Eur J Heart Fail 12 2010 721 729
14. H.F. Tse, S. Thambar, and Y.L. Kwong Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for treatment of severe coronary artery diseases (PROTECT-CAD trial) Eur Heart J 28 2007 2998 3005
15. R.J. van, J.J. Bax, and S.L. Beeres Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial JAMA 301 2009 1997 2004
16. N. Dib, J. Dinsmore, and Z. Lababidi One-year follow-up of feasibility and safety of the first U.S., randomized, controlled study using 3-dimensional guided catheter-based delivery of autologous skeletal myoblasts for ischemic cardiomyopathy (CAuSMIC study) JACC Cardiovasc Interv 2 2009 9 16
17. H.J. Duckers, J. Houtgraaf, and C. Hehrlein Final results of a phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: the SEISMIC trial EuroIntervention 6 2011 805 812
18. P. Menasche, O. Alfieri, and S. Janssens The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation Circulation 117 2008 1189 1200
19. T.J. Povsic, C.M. O'Connor, and T. Henry A double-blind, randomized, controlled, multicenter study to assess the safety and cardiovascular effects of skeletal myoblast implantation by catheter delivery in patients with chronic heart failure after myocardial infarction Am Heart J 162 2011 654 662
20. A.B. Mathiasen, M. Haack-Sorensen, and J. Kastrup Mesenchymal stromal cells for cardiovascular repair: current status and future challenges Future Cardiol 5 2009 605 617
21. M.L. da Silva, P.C. Chagastelles, and N.B. Nardi Mesenchymal stem cells reside in virtually all post-natal organs and tissues J Cell Sci 119 2006 2204 2213
22. M. Haack-Sorensen, T. Friis, L. Bindslev, S. Mortensen, H.E. Johnsen, and J. Kastrup Comparison of different culture conditions for human mesenchymal stromal cells for clinical stem cell therapy Scand J Clin Lab Invest 68 2008 192 203
23. S. Chen, Z. Liu, and N. Tian Intracoronary transplantation of autologous bone marrow mesenchymal stem cells for ischemic cardiomyopathy due to isolated chronic occluded left anterior descending artery J Invasive Cardiol 18 2006 552 556
24. S.L. Chen, W.W. Fang, and F. Ye Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction Am J Cardiol 94 2004 92 95
25. T. Friis, M. Haack-Sorensen, and A.B. Mathiasen Mesenchymal stromal cell derived endothelial progenitor treatment in patients with refractory angina Scand Cardiovasc J 45 2011 161 168
26. M. Haack-Sorensen, T. Friis, and A.B. Mathiasen Direct intramyocardial mesenchymal stromal cell injections in patients with severe refractory angina - one year follow-up Cell Transplant 22 2013 521 528
27. J.M. Hare, J.H. Traverse, and T.D. Henry A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction J Am Coll Cardiol 54 2009 2277 2286
28. J.H. Houtgraaf, W.K. den Dekker, and B.M. van Dalen First experience in humans using adipose tissue-derived regenerative cells in the treatment of patients with ST-segment elevation myocardial infarction J Am Coll Cardiol 59 2012 539 540
29. D.G. Katritsis, P.A. Sotiropoulou, and E. Karvouni Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium Catheter Cardiovasc Interv 65 2005 321 329
30. D.G. Katritsis, P. Sotiropoulou, E. Giazitzoglou, E. Karvouni, and M. Papamichail Electrophysiological effects of intracoronary transplantation of autologous mesenchymal and endothelial progenitor cells Europace 9 2007 167 171
31. M. Haack-Sorensen, L. Bindslev, S. Mortensen, T. Friis, and J. Kastrup The influence of freezing and storage on the characteristics and functions of human mesenchymal stromal cells isolated for clinical use Cytotherapy 9 2007 328 337
32. J. Kastrup, E. Jorgensen, and A. Ruck Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One Trial J Am Coll Cardiol 45 2005 982 988
33. F. Baldazzi, E. Jorgensen, R.S. Ripa, and J. Kastrup Release of biomarkers of myocardial damage after direct intramyocardial injection of genes and stem cells via the percutaneous transluminal route Eur Heart J 29 2008 1819 1826
34. R.S. Ripa, Y. Wang, E. Jorgensen, H.E. Johnsen, B. Hesse, and J. Kastrup Intramyocardial injection of vascular endothelial growth factor-A165 plasmid followed by granulocyte-colony stimulating factor to induce angiogenesis in patients with severe chronic ischaemic heart disease Eur Heart J 27 2006 1785 1792
35. M. Dominici, B.K. Le, and I. Mueller Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement Cytotherapy 8 2006 315 317
36. A.B. Mathiasen, E. Jorgensen, A.A. Qayyum, M. Haack-Sorensen, A. Ekblond, and J. Kastrup Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial) Am Heart J 164 2012 285 291
37. A.A. Qayyum, M. Haack-Sorensen, A.B. Mathiasen, E. Jorgensen, A. Ekblond, and J. Kastrup Adipose-derived mesenchymal stromal cells for chronic myocardial ischemia (MyStromalCell Trial): study design Regen Med 7 2012 421 428
38. G. Cobellis, C. Maione, and C. Botti Beneficial effects of VEGF secreted from stromal cells in supporting endothelial cell functions: therapeutic implications for critical limb ischemia Cell Transplant 19 2010 1425 1437
39. J. Westrich, P. Yaeger, and C. He Factors affecting residence time of mesenchymal stromal cells (MSC) injected into the myocardium Cell Transplant 19 2010 937 948
40. H. Yagi, A. Soto-Gutierrez, and B. Parekkadan Mesenchymal stem cells: mechanisms of immunomodulation and homing Cell Transplant 19 2010 667 679
41. S. Nikol, and M. Kuhlmann Mobilization of stem cells in cardiovascular disease. Improvement of vascularization, cardiac function and arrhythmias Med Klin (Munich) 101 Suppl. 1 2006 190 192
42. L. Timmers, S.K. Lim, and I.E. Hoefer Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction Stem Cell Res 6 2011 206 214
43. C. Bearzi, M. Rota, and T. Hosoda Human cardiac stem cells Proc Natl Acad Sci U S A 104 2007 14068 14073
44. S.A. Chamuleau, K.R. Vrijsen, D.G. Rokosh, X.L. Tang, J.J. Piek, and R. Bolli Cell therapy for ischaemic heart disease: focus on the role of resident cardiac stem cells Neth Heart J 17 2009 199 207
45. T. Freyman, G. Polin, and H. Osman A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction Eur Heart J 27 2006 1114 1122